Bristol-Myers Squibb Company News Headlines

BMY 
$50.53
*  
0.65
1.27%
Get BMY Alerts
*Delayed - data as of Oct. 1, 2014  -  Find a broker to begin trading BMY now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    BMY After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Bristol-Myers' Opdivo under Review in EU for Lung Cancer - Analyst Blog
10/1/2014 5:00:00 PM - Zacks.com

AbbVie Announces Positive Results on Oncology Candidate - Analyst Blog
10/1/2014 4:30:00 PM - Zacks.com

BMY Makes Notable Cross Below Critical Moving Average
10/1/2014 11:37:37 AM - BNK Invest

Abbott Labs Completes CFR Pharmaceuticals Acquisition - Analyst Blog
10/1/2014 9:50:00 AM - Zacks.com

U.S. Hot Stocks: Hot Stocks to Watch
10/1/2014 9:32:00 AM - Dow Jones Business News

Portola Pharma: Phase 3 ANNEXA-A Study Of Andexanet Alfa, Eliquis Met Endpoints
10/1/2014 8:26:00 AM - RTT News

Big money flowing to from med firms to docs
10/1/2014 8:21:00 AM - Seeking Alpha

Bristol-Myers To Transfer $1.4 Bln In U.S. Pension Obligations To Prudential
9/30/2014 5:14:00 PM - RTT News

Valeant's Bausch + Lomb Announces Results on Lotemax - Analyst Blog
9/30/2014 12:10:00 PM - Zacks.com

Big News for These 5 Stocks From ESMO
9/30/2014 9:05:02 AM - Motley Fool

Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 01, 2014
9/30/2014 9:00:02 AM - NASDAQ.com News

Bristol-Myers' Opdivo Under Review in US, EU for Cancer Treatment - Analyst Blog
9/29/2014 6:50:00 PM - Zacks.com

Roche Releases Data from CLEOPATRA Study on Perjeta - Analyst Blog
9/29/2014 4:50:00 PM - Zacks.com

Novartis Gives Updates on Signifor LAR and Secukinumab - Analyst Blog
9/29/2014 4:35:00 PM - Zacks.com

Celgene Has A Very Bright Future Ahead
9/29/2014 4:26:00 PM - Seeking Alpha

Notable ETF Inflow Detected - XLV, JNJ, AMGN, BMY
9/29/2014 10:52:48 AM - BNK Invest

Gilead Sciences, Inc. Takes Aim at Bristol-Myers Squibb
9/29/2014 8:35:02 AM - Motley Fool

Bristol-Myers: EMA Validates Marketing Authorization Application For Nivolumab
9/29/2014 8:26:00 AM - RTT News

Bristol-Myers Squibb Announces Positive Phase 3 Data For Opdivo - Quick Facts
9/29/2014 3:21:00 AM - RTT News

Allergan Writes Back, Coaxes Shareholders Against Valeant - Analyst Blog
9/26/2014 5:00:00 PM - Zacks.com

Gilead's HIV Drugs Tybost and Vitekta Get FDA Clearance - Analyst Blog
9/26/2014 4:30:00 PM - Zacks.com

Pfizer Acquires InnoPharma, Injectables Business to Benefit - Analyst Blog
9/26/2014 4:20:00 PM - Zacks.com

Is Gilead Still Cheap?
9/26/2014 3:03:00 PM - Seeking Alpha

Roche Announces Positive Results from Studies on Avastin - Analyst Blog
9/26/2014 1:00:00 PM - Zacks.com

Let's Talk About The Nifty Fifty And Dividend Growth Investing
9/25/2014 9:23:00 PM - Seeking Alpha